CLBCX
Price
$40.90
Change
+$0.34 (+0.84%)
Updated
Jun 18 closing price
Net Assets
287.61B
CSGCX
Price
$46.62
Change
+$0.40 (+0.87%)
Updated
Jun 18 closing price
Net Assets
1.49B
Interact to see
Advertisement

CLBCX vs CSGCX

CLBCX vs CSGCX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. CSGCX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Hold and CSGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 288B vs. CSGCX (1.49B). CLBCX pays higher dividends than CSGCX: CLBCX (1.10) vs CSGCX (0.63). CLBCX was incepted earlier than CSGCX: CLBCX (24 years) vs CSGCX (32 years). CSGCX (1.65) is less costly to investors than CLBCX (1.35). CSGCX is a more actively managed with annual turnover of: 164.00 vs. CLBCX (50.00). CLBCX has a lower initial minimum investment than CSGCX: CLBCX (250) vs CSGCX (1000). CLBCX annual gain was more profitable for investors over the last year : 16.05 vs. CSGCX (9.24). CLBCX return over 5 years is better than : 34.34 vs. CSGCX (20.54).
CLBCXCSGCXCLBCX / CSGCX
Total Expense Ratio1.351.6582%
Annual Report Gross Expense Ratio1.351.6582%
Fund Existence24 years32 years-
Gain YTD9.3323.540264%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B1.49B19,342%
Annual Yield % from dividends1.100.63173%
Returns for 1 year16.059.24174%
Returns for 3 years36.6832.58113%
Returns for 5 years34.3420.54167%
Returns for 10 years84.8771.28119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGRAX48.680.88
+1.84%
Franklin Growth Opportunities A
BSMKX22.080.39
+1.80%
iShares Russell Small/Mid-Cap Idx K
VYMYX19.030.33
+1.76%
Voya MI Dynamic SMID Cap W
SGQAX48.730.71
+1.48%
DWS International Opportunities A
RERFX64.330.57
+0.89%
American Funds EUPAC R5